NeuroMagen Pharma is developing a novel drug that boosts the effectiveness of telomerase as a neuroprotector in order to delay the onset and progression of ALS.
Company Founded Year
Company Number of Employees
NeuroPharmacology | NeuroBioTechnology
Biotechnology & Biopharmaceutical
Medical use (pharma, nerve damage rehabilitation, neurodiagnostics. inc. early diagnosis)
Biochemical: pharmacological drugs (Developing drugs)